Cargando…
1208. Development of a Novel Synthetic Glycan to Prevent Bacterial Infections and Ameliorate Respiratory Viral Infections
BACKGROUND: The prevention and treatment of bacterial infections is a human health challenge. A disadvantage of antibiotics is that they often kill beneficial commensal, bacteria in addition to, pathogenic bacteria. Indiscriminate killing disrupts the homeostasis between commensal bacteria and the h...
Autores principales: | Meisner, Jeffrey, Lee, Jackson, Lawrence, Jonathan, Roed, Megan, Vlieg, Johan van Hylckama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776774/ http://dx.doi.org/10.1093/ofid/ofaa439.1393 |
Ejemplares similares
-
Synthetic glycans control gut microbiome structure and mitigate colitis in mice
por: Tolonen, Andrew C., et al.
Publicado: (2022) -
COLLABORATION AGREEMENT No. K 1208 & K 1397
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005) -
Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract
por: Kiedrowski, Megan R., et al.
Publicado: (2018) -
1208. Omadacycline In Vitro Activity Against Bacillus Anthracis
por: Serio, Alisa W, et al.
Publicado: (2021) -
1208. Impact of Admission to an Inpatient Infectious Disease Unit on Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Mirza, Zainab Farooqui, et al.
Publicado: (2018)